Air quality of health facilities in Spain.

Autor: López A; Foundation for the Promotion of Health and Biomedical Research in the Valencia Region, FISABIO-Public Health, 21, Avenida Catalunya, 46020, Valencia, Spain. Electronic address: antonio.lopez@fisabio.es., Fuentes-Ferragud E; Foundation for the Promotion of Health and Biomedical Research in the Valencia Region, FISABIO-Public Health, 21, Avenida Catalunya, 46020, Valencia, Spain; Environmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, S/N, Avenida Sos Baynat, 12071 Castelló de la Plana, Spain., Mora MJ; Foundation for the Promotion of the Health and Biomedical Research in the Valencian Region, FISABIO-Xativa/Ontinyent Department, 21, Ctra. Xàtiva-Silla, km. 2, Xàtiva, 46800, Valencia, Spain; Foundation for the Promotion of the Health and Biomedical Research in the Valencian Region, FISABIO-Alcoy Departament, Polígono Caramanxell, s/n. 03804 Alcoy, Alicante, Spain., Blasco-Ferre J; Foundation for the Promotion of the Health and Biomedical Research in the Valencian Region, FISABIO-Xativa/Ontinyent Department, 21, Ctra. Xàtiva-Silla, km. 2, Xàtiva, 46800, Valencia, Spain., Barber G; Foundation for the Promotion of the Health and Biomedical Research in the Valencian Region, FISABIO-Xativa/Ontinyent Department, 21, Ctra. Xàtiva-Silla, km. 2, Xàtiva, 46800, Valencia, Spain., Lopez-Labrador FX; Foundation for the Promotion of Health and Biomedical Research in the Valencia Region, FISABIO-Public Health, 21, Avenida Catalunya, 46020, Valencia, Spain; Microbiology Department, University of Valencia Medical School, 13, Av. Blasco Ibáñez, 46010, Valencia, Spain; CIBERESP, Instituto de Salud Carlos III (Institute of Health Carlos III), Madrid, Spain., Camaró M; Public Health Laboratory of Valencia, 21, Avenida Catalunya, 46020 Valencia, Spain., Coscollà C; Foundation for the Promotion of Health and Biomedical Research in the Valencia Region, FISABIO-Public Health, 21, Avenida Catalunya, 46020, Valencia, Spain.

Publikováno v: Chemosphere [Chemosphere] 2024 Aug; Vol. 362, pp. 142615. Date of Electronic Publication: 2024 Jun 14.

Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study

Autor: Aguilera, V, Di Maira, T, Conde, I, Fornes-Ferrer, V, Vinaixa, C, Pallares, C, Carvalho-Gomes, A, Cubells, A, Garcia, M, Rubin, A, Benlloch, S, Gonzalez-Dieguez, L, Molina, JM, Puchades, L, Lopez-Labrador, FX, Prieto, M, Berenguer, M

Publikováno v: TRANSPLANT INTERNATIONAL
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

The association between cytomegalovirus (CMV) reactivation and cardiovascular risk has been reported in solid organ transplant populations; however, it has yet to be assessed in liver transplantation (LT). We aim to evaluate whether CMV reactivation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8ce232bdee08ae6f5c69b5dd4ea51775
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2607

Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples.

Autor: de Vries JJC; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: jjcdevries@lumc.nl., Brown JR; Microbiology, Virology and Infection Prevention & Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Electronic address: julianne.brown@gosh.nhs.uk., Fischer N; University Medical Center Hamburg-Eppendorf, UKE Institute for Medical Microbiology, Virology and Hygiene, Germany. Electronic address: nfischer@uke.de., Sidorov IA; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: I.A.Sidorov@lumc.nl., Morfopoulou S; Division of Infection and Immunity, University College London, London, United Kingdom. Electronic address: sofia.morfopoulou.10@ucl.ac.uk., Huang J; University Medical Center Hamburg-Eppendorf, UKE Institute for Medical Microbiology, Virology and Hygiene, Germany. Electronic address: j.huang@uke.de., Munnink BBO; Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: b.oudemunnink@erasmusmc.nl., Sayiner A; Dokuz Eylul University, Medical Faculty, Izmir, Turkey. Electronic address: arzu.sayiner@deu.edu.tr., Bulgurcu A; Hospital Henri Mondor, Paris, France., Rodriguez C; Hospital Henri Mondor, Paris, France. Electronic address: christophe.rodriguez@aphp.fr., Gricourt G; Hospital Henri Mondor, Paris, France. Electronic address: guillaume.gricourt@aphp.fr., Keyaerts E; Laboratory of Clinical and Epidemiological Virology (Rega Institute), KU Leuven, Belgium. Electronic address: els.keyaerts@kuleuven.be., Beller L; Laboratory of Clinical and Epidemiological Virology (Rega Institute), KU Leuven, Belgium. Electronic address: leen.beller@kuleuven.be., Bachofen C; Institute of Virology, University of Zurich, Switzerland. Electronic address: claudia.bachofen@uzh.ch., Kubacki J; Institute of Virology, University of Zurich, Switzerland. Electronic address: jakub.kubacki@uzh.ch., Samuel C; Laboratory of Virology, University Hospitals of Geneva, Geneva, Switzerland. Electronic address: Samuel.Cordey@hcuge.ch., Florian L; Laboratory of Virology, University Hospitals of Geneva, Geneva, Switzerland. Electronic address: Florian.Laubscher@hcuge.ch., Dennis S; RIVM National Institute for Public Health and Environment, Bilthoven, the Netherlands. Electronic address: Dennis.Schmitz@RIVM.nl., Beer M; Friedrich-Loeffler-Institute, Institute of Diagnostic Virology, Greifswald, Germany. Electronic address: martin.beer@fli.de., Hoeper D; Friedrich-Loeffler-Institute, Institute of Diagnostic Virology, Greifswald, Germany. Electronic address: dirk.hoeper@fli.de., Huber M; Institute of Medical Virology, University of Zurich, Switzerland. Electronic address: huber.michael@virology.uzh.ch., Kufner V; Institute of Medical Virology, University of Zurich, Switzerland. Electronic address: kufner.verena@virology.uzh.ch., Zaheri M; Institute of Medical Virology, University of Zurich, Switzerland. Electronic address: zaheri.maryam@virology.uzh.ch., Lebrand A; Swiss Institute of Bioinformatics, Geneva, Switzerland. Electronic address: aitana.lebrand@sib.swiss., Papa A; Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Greece. Electronic address: annap@auth.gr., van Boheemen S; Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: s.vanboheemen@erasmusmc.nl., Kroes ACM; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: A.C.M.Kroes@lumc.nl., Breuer J; Microbiology, Virology and Infection Prevention & Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Division of Infection and Immunity, University College London, London, United Kingdom. Electronic address: breuej@gosh.nhs.uk., Lopez-Labrador FX; Virology Laboratory, Genomics and Health Area, Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana and Microbiology & Ecology Department, University of Valencia, Spain; CIBERESP, Instituto de Salud Carlos III, Spain. Electronic address: F.Xavier.Lopez@uv.es., Claas ECJ; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: E.C.J.Claas@lumc.nl.

Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2021 Aug; Vol. 141, pp. 104908. Date of Electronic Publication: 2021 Jul 08.

Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results

Autor: Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, Belenguer-Varea A, Carballido-Fernandez M, Carbonell-Franco E, Carratala-Munuera C, Limon-Ramirez R, Mollar-Maseres J, Del Carmen Otero-Reigada M, Schwarz-Chavarri G, Tuells J, Gil-Guillen V

Publikováno v: Eurosurveillance
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación Universitaria San Pablo CEU (FUSPCEU)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scopus-Elsevier
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

Preliminary results for the 2014/15 season indicate low to null effect of vaccination against influenza A(H3N2)-related disease. As of week 5 2015, there have been 1,136 hospital admissions, 210 were due to influenza and 98% of subtype A strains were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::399ed699f0e7beaa0b32e8c5d45208b4
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8747

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.